CNSDose is a pharmacogenomic test that optimises mental health medication selection by incorporating genetics that influence both liver metabolism and blood-brain barrier efflux. CNSDose seeks to improve drug efficacy and reduce side-effects by helping clinicians select appropriate medications and d...See more
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2012 (14 years)
Address:
MELBOURNE, AU
Employees by Department
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has CNSDOSE been operating for?
- What is the funding status of CNSDOSE?
- Where is CNSDOSE's headquarter?
- What CNSDOSE's spending power?
- Does CNSDOSE have a presence in the domain it operates in?

